Status:
UNKNOWN
The Effect of Remifentanil on Established Capsaicin-Induced Hyperalgesia in Human Volunteers
Lead Sponsor:
Medical University of Vienna
Conditions:
Hyperalgesia
Eligibility:
All Genders
19-40 years
Phase:
PHASE4
Brief Summary
Treatment of chronic pain is a major clinical challenge since chronic pain is frequent and leads to deterioration of quality of life. An injury or wound can lead to long term changes in the nervous sy...
Eligibility Criteria
Inclusion
- Body mass index between 15th and 85th percentile
- Normal findings in the medical history and physical examination
- Drug free for 1 week prior to the study day
Exclusion
- Regular use of medication especially analgesics
- Abuse of alcoholic beverages, drug abuse
- History of asthma
- Participation in a clinical trial in the 2 weeks preceding the study
- Symptoms of a clinically relevant illness in the 2 weeks before the first study day
- Resting systolic blood pressure \> 135 mmHg or diastolic blood pressure \> 85 mmHg
- Acute skin diseases like sunburn on the relevant areas or skin lesions
- Pregnancy or breast feeding
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00789386
Start Date
November 1 2008
End Date
December 1 2009
Last Update
May 21 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anaesthesia, Medical University of Vienna
Vienna, Austria, 1090